Search This Blog

Thursday, May 7, 2026

Xeris books profit, ups guidance

 

Xeris Biopharma posts Q1 2026 profit with EPS $0.01 on $83.1M revenue, beats estimates and raises 2026 guidance to $380–$390M

  • Q1 2026 results represent a return to net income for Xeris Biopharma.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)